Bladder cancer selective chemotherapy with potent NQO1 substrate co-loaded prodrug nanoparticles.
J Control Release
; 347: 632-648, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35618186
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Prodrugs
/
Nanoparticles
Limits:
Humans
Language:
En
Journal:
J Control Release
Journal subject:
FARMACOLOGIA
Year:
2022
Type:
Article
Affiliation country:
China